/PRNewswire/ Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody.
EQS-News: ABIVAX / Key word: Miscellaneous
Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months
22.01.2024 / 08:30 CET/CEST
The.
Patients responding well to new active ulcerative colitis treatment eturbonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eturbonews.com Daily Mail and Mail on Sunday newspapers.
Inflammatory Bowel Disease Market Size, Share Analysis, Growth and Forecast Report 2023 - 2030 | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
Merck Completes Acquisition of Prometheus Biosciences, Inc. pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.